May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Hematopoietic Specific Signal Transducer Vav1 Is Expressed in Human Uveal Melanoma
Author Affiliations & Notes
  • L. Pe'er
    Humphrey Center for Expt. Med. & Cancer, Hebrew Univ.-Hadassah Medical School, Jerusalem, Israel
  • G. Lazer
    Humphrey Center for Expt. Med. & Cancer, Hebrew Univ.-Hadassah Medical School, Jerusalem, Israel
  • T. Meir
    Ophthalmology, Hadassah-Hebrew Univ. Medical Center, Jerusalem, Israel
  • I. Chowers
    Ophthalmology, Hadassah-Hebrew Univ. Medical Center, Jerusalem, Israel
  • J. Pe'er
    Ophthalmology, Hadassah-Hebrew Univ. Medical Center, Jerusalem, Israel
  • S. Katzav
    Humphrey Center for Expt. Med. & Cancer, Hebrew Univ.-Hadassah Medical School, Jerusalem, Israel
  • Footnotes
    Commercial Relationships  L. Pe'er, None; G. Lazer, None; T. Meir, None; I. Chowers, None; J. Pe'er, None; S. Katzav, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 72. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Pe'er, G. Lazer, T. Meir, I. Chowers, J. Pe'er, S. Katzav; The Hematopoietic Specific Signal Transducer Vav1 Is Expressed in Human Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2008;49(13):72. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Uveal melanomas, like other cancers, are the result of multiple aberrations, including activation of dominant oncogenes and upregulation of signal transduction pathways. One signal transducer protein that was originally detected as an oncogene is Vav1, which under physiological conditions is exclusively expressed in the hematopoietic system. Aberrant expression of wild-type Vav1 has recently been associated with both neuroblastoma and pancreatic ductal carcinoma. The purpose of this pilot study is to determine whether Vav1 is ectopically expressed in uveal melanoma.

Methods: : Histological slides of 14 uveal melanomas, 10 primary tumors and 4 metastatic tumors, were stained by immunohistochemistry with antibodies specific for Vav1. Ten RNA samples of uveal melanomas, 7 primary tumors and 3 metastatic tumors, were evaluated by RT-PCR for expression of Vav1.

Results: : Eleven of the uveal melanoma slides (9 primary and 2 metastases) were positive for immunostaining with the Vav1 oncogene in tumor cells. Three of the RNA samples were positive for the Vav1 oncogene.

Conclusions: : Aberrant Vav1 expression is present in uveal melanoma. Given Vav1's known role in other malignancies, our data suggest that Vav1 may potentially be implicated in the pathogenesis of uveal melanoma.

Keywords: tumors • melanoma • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×